MICM
ONC

Matthews International Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Matthews International Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,902
Closed -$3.77M – 42
2023
Q4 		$3.77M Sell
20,902
-39,988
-66% -$7.23M 0.53% 25
2023
Q3 		$11M Sell
60,890
-66,847
-52% -$13.2M 1.32% 18
2023
Q2 		$22.8M Sell
127,737
-9,221
-7% -$2.12M 2.67% 8
2023
Q1 		$29.5M Buy
136,958
+13,831
+11% +$3.32M 2.95% 11
2022
Q4 		$27.1M Sell
123,127
-39,373
-24% -$7.22M 3.2% 10
2022
Q3 		$21.9M Sell
162,500
-15,092
-8% -$2.59M 3.18% 8
2022
Q2 		$28.7M Hold
177,592
– – 4.13% 7
2022
Q1 		$33.5M Sell
177,592
-55,200
-24% -$11.7M 4.64% 8
2021
Q4 		$63.1M Sell
232,792
-11,700
-5% -$3.95M 6.59% 5
2021
Q3 		$88.8M Buy
244,492
+800
+0.3% +$262K 5.38% 6
2021
Q2 		$83.6M Buy
243,692
+200
+0.1% +$66.2K 3.48% 8
2021
Q1 		$84.8M Buy
243,492
+28,900
+13% +$9.57M 3.54% 8
2020
Q4 		$55.4M Sell
214,592
-1,000
-0.5% -$275K 2.95% 9
2020
Q3 		$61.8M Sell
215,592
-32,000
-13% -$7.52M 4.16% 8
2020
Q2 		$46.6M Sell
247,592
-24,400
-9% -$3.97M 3.63% 11
2020
Q1 		$33.5M Buy
271,992
+61,189
+29% +$9.57M 2.15% 9
2019
Q4 		$34.9M Buy
210,803
+22,700
+12% +$3.77M 1.67% 14
2019
Q3 		$23M Sell
188,103
-112,200
-37% -$14.9M 1.03% 17
2019
Q2 		$37.2M Buy
300,303
+66,700
+29% +$8.47M 1.68% 14
2019
Q1 		$30.8M Sell
233,603
-9,800
-4% -$1.32M 1.45% 16
2018
Q4 		$34.1M Buy
243,403
+36,300
+18% +$4.81M 2.09% 12
2018
Q3 		$35.7M Buy
207,103
+32,200
+18% +$5.41M 1.71% 12
2018
Q2 		$26.9M Buy
174,903
+51,600
+42% +$9.2M 1.2% 14
2018
Q1 		$20.7M Buy
+123,303
New +$16.7M 0.94% 14

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Matthews International Capital Management's ONC Position: Q1 2024 in Review

Matthews International Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 20,902 shares — an estimated $3.77M sold.

Matthews International Capital Management first reported a position in ONC in Q1 2018 and held it in 24 quarters. The position peaked at $88.8M in Q3 2021. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • Matthews International Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • Matthews International Capital Management sold 20,902 BeOne Medicines Ltd shares in Q1 2024, an estimated $3.77M.
  • Matthews International Capital Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 24 quarters.
  • Matthews International Capital Management's BeOne Medicines Ltd position peaked at $88.8M in Q3 2021.
  • 205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on Matthews International Capital Management's 13F filing for Q1 2024, filed 15 Apr 2024.